Lam Research Corporation is rated Buy with a 12-month price target of $360 to $380, up from its current price around $303. The positive outlook is based on the company's leadership in semiconductor etch and deposition equipment and the structural growth driven by AI-related chip complexity. Despite a high trailing P/E ratio above 60 and challenges related to China, these factors are considered priced in, suggesting patient investors could benefit over the next 12 to 24 months as earnings normalize mid-cycle.
Asian semiconductor stocks experienced a significant decline following a sell-off in US chipmakers, with SK Hynix shares dropping over 9% in Seoul after an earlier 8% rally. The sell-off reflects concerns over AI spending and profit-taking after a st...
REX Shares has filed for the REX AI Chipmaking ETF, targeting the booming $1.3 trillion AI infrastructure sector. The fund tracks the VettaFi AI Chipmaking Index, focusing on companies involved in wafer fabrication equipment, advanced packaging, and ...
The FTSE 100 index fell slightly, dragged down by mining stocks reacting to China's slower GDP growth of 4.3% in Q2, its weakest in three years. Despite this, oil prices remained steady amid US-Iran tensions. PayPal shares jumped over 14% following r...
The iShares A.I. Innovation and Tech Active ETF (BAI) fell nearly 6% in one week after a strong year-to-date gain of about 36%. This volatility reflects sensitivity to the 10-year Treasury yield, which affects valuations of AI-related semiconductor s...
Lam Research's stock has surged over 120% in seven months, far outperforming the benchmark's 11% gain. However, its current forward price-to-earnings ratio of 62x is significantly higher than its peers at 25x, raising concerns about overvaluation. De...
